Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells-Reference-Cited by-同舟云学术

Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells

Published:2015-06 Issue:25 Volume:290 Page:15812-15824
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Tan Bo,Dong Sucai,Shepard Robert L.,Kays Lisa,Roth Kenneth D.,Geeganage Sandaruwan,Kuo Ming-Shang,Zhao Genshi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications;Tan;J. Biol. Chem,2013

2. Nampt: linking NAD+ biology, metabolism and cancer;Garten;Trends Endocrinol. Metab,2009

3. Niacin status, NAD distribution and ADP-ribose metabolism;Kirkland;Curr. Pharm. Des,2009

4. Enzymology of NAD+ homeostasis in man;Magni;Cell Mol. Life Sci,2004

5. NAD+ and vitamin B3: from metabolism to therapies;Sauve;J. Pharmacol. Exp. Ther,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in triple-negative breast cancer;Nature Communications;2024-07-05

2. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review;Expert Opinion on Therapeutic Patents;2024-06-13

3. TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in Triple-Negative Breast Cancer;2024-05-17

4. Reproductive Ageing: Metabolic contribution to age-related chromosome missegregation in mammalian oocytes;Reproduction;2024-05-07

5. Machine Learning-Based Metabolic Pattern Recognition Predicts Mode of Action for Anti-Cancer Drug Candidates;2024-01-26